| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,648.5720 | 3,710.7140 | 0 | 19,346.3060 | 4,832.2780 |
| Cost of Revenue
|
-1,494.3300 | -1,360.3110 | -475.2120 | -13,111.4970 | -3,439.0260 |
|
Gross Profit
|
2,154.2420 | 2,350.4030 | -475.2120 | 6,234.8090 | 1,393.2520 |
| Selling, General and Administrative Expenses
|
-1,984.9290 | -2,177.2990 | -1,677.3260 | -4,021.5560 | -2,022.8820 |
|
Research and Development Expenses
|
-- | -- | -- | -458.8890 | -470.8030 |
|
Accretion of Asset Retirement Obligation
|
-1,912.9680 | -1,912.9680 | -- | -- | -- |
|
Operating Income/Expenses
|
-6,849.4280 | -4,090.2670 | -1,677.3260 | -4,021.5560 | -2,493.6850 |
|
Total Operating Profit/Loss
|
-4,695.1860 | -1,739.8640 | -2,152.5380 | 2,213.2530 | -1,100.4330 |
| Total Net Finance Income/Expense
|
-142.1930 | -251.9260 | -248.5670 | -498.4590 | -81.1780 |
| Irregular Income/Expenses
|
15,472.8500 | 21,101.0020 | -738.9130 | 1,875.1500 | 109.4350 |
|
Other Income/Expense, Non-Operating
|
560.4020 | 83.6270 | 39.2270 | 0 | 0 |
|
Non-Operating Income/Expenses, Total
|
15,891.0590 | 20,932.7030 | -948.2530 | 1,376.6910 | 28.2570 |
|
Pretax Income
|
11,195.8730 | 19,192.8390 | -3,100.7910 | 3,589.9440 | -1,072.1760 |
|
Provision for Income Tax
|
0 | 0 | -77.3680 | 0 | -- |
|
Net Income from Continuing Operations
|
11,195.8730 | 19,192.8390 | -3,178.1590 | 3,589.9440 | -1,072.1760 |
|
Discontinued Operations
|
-25.1610 | -25.1610 | -6,619.9240 | -458.8890 | -- |
|
Net Income after Extraordinary Items and Discontinued Operations
|
11,170.7120 | 19,167.6780 | -9,798.0830 | 3,131.0550 | -1,072.1760 |
|
Net Income after Non-Controlling/Minority Interests
|
11,170.7120 | 19,167.6780 | -9,798.0830 | 3,131.0550 | -1,072.1760 |
|
Net Income Available to Common Stockholders
|
11,170.7120 | 19,167.6780 | -9,798.0830 | 3,131.0550 | -1,072.1760 |
|
Diluted Net Income Available to Common Stockholders
|
11,170.7120 | 19,167.6780 | -9,798.0830 | 3,131.0550 | -1,072.1760 |
| Basic EPS
|
0.11 | 0.18 | -0.09 | 0.03 | -0.02 |
| Diluted EPS
|
0.11 | 0.18 | -0.09 | 0.03 | -0.02 |
|
Basic Weighted Average Shares Outstanding
|
113,297.7180 | 109,350.9330 | 104,727.1890 | 83,129.6370 | 68,112.2480 |
|
Diluted Weighted Average Shares Outstanding
|
113,297.7180 | 109,350.9330 | 104,727.1890 | 83,129.6370 | 68,112.2480 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
11,338.0660 | 19,444.7650 | -2,852.2240 | 4,088.4030 | -990.9980 |
|
EBITDA
|
13,723.1780 | 20,621.8850 | -2,762.2770 | 5,869.9760 | -595.4550 |
|
Normalized EBITDA
|
-1,495.6430 | -120.3950 | 2,470.9170 | 4,381.3560 | -311.6300 |
|
Normalized Income
|
-826.9956 | -1,549.4410 | 1,113.8627 | 2,101.3240 | -788.3510 |
|
Total Unusual Items
|
-15,218.8210 | -20,742.2800 | 5,233.1940 | -1,488.6200 | 283.8250 |
12/31/2022 - 3/27/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade